A study by Thybusch-Bernhardt et al. suggested that HER1 and HER2 overexpression contributes to a more aggressive phenotype and that lack of HER4 expression may increase the metastatic capacity of pancreatic cancer cells [34]. The gene discussed is EGFR; the disease is pancreatic neoplasm.